Myofibroblasts in murine cutaneous fibrosis originate from adiponectin-positive intradermal progenitors

Arthritis and Rheumatology

Volumn 67, Issue 4, 2015, Pages 1062-1073

  Marangoni, Roberta Goncalves ^a   Korman, Benjamin D ^a   Wei, Jun ^a   Wood, Tammara A ^b   Graham, Lauren V ^a   Whitfield, Michael L ^b   Scherer, Philipp E ^c   Tourtellotte, Warren G ^a   Varga, John ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b DARTMOUTH MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; BLEOMYCIN; COLLAGEN 1 ALPHA 1; COLLAGEN 1 ALPHA 2; COLLAGEN 1 ALPHA 5; CRE RECOMBINASE; FIBRONECTIN; KRUPPEL LIKE FACTOR; KRUPPEL LIKE FACTOR 7; MICROFIBRILLAR ASSOCIATED PROTEIN 4; PLASMINOGEN ACTIVATOR INHIBITOR 1; SECRETED FRIZZLED RELATED PROTEIN 1; SILENCING MEDIATOR OF RETINOID AND THYROID HORMONE RECEPTOR; TENASCIN; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ADIPOCYTE; ADIPOCYTE MYOFIBROBLAST TRANSITION; ADIPOGENESIS; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DIFFERENTIATION; CELL FATE; CELL TRANSFORMATION; CONTROLLED STUDY; EX VIVO STUDY; FEMALE; FIBROGENESIS; GENE MAPPING; MALE; MOUSE; MYOFIBROBLAST; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SCLERODERMA; SKIN DEFECT; SKIN FIBROBLAST; SKIN FIBROSIS; SUBCUTANEOUS FAT; TRANSGENIC MOUSE; ANIMAL; CELL LINEAGE; CHEMICALLY INDUCED; DISEASE MODEL; FIBROSIS; METABOLISM; PATHOLOGY; SKIN; SKIN DISEASE; SYSTEMIC SCLEROSIS;

ADIPOCYTES; ADIPONECTIN; ANIMALS; BLEOMYCIN; CELL LINEAGE; DISEASE MODELS, ANIMAL; FIBROSIS; MICE; MYOFIBROBLASTS; SCLERODERMA, SYSTEMIC; SKIN; SKIN DISEASES;

EID: 84925813798     PISSN: 23265191     EISSN: 23265205     Source Type: Journal    
DOI: 10.1002/art.38990     Document Type: Article

References (47)

1. Gabrielli A, Avvedimento EV, Krieg T,. Scleroderma. N Engl J Med 2009; 360: 1989-2003.
2. Jimenez SA, Derk CT,. Following the molecular pathways toward an understanding of the pathogenesis of systemic sclerosis. Ann Intern Med 2004; 140: 37-50.
3. Hinz B, Phan SH, Thannickal VJ, Prunotto M, Desmouliere A, Varga J, et al. Recent developments in myofibroblast biology: paradigms for connective tissue remodeling. Am J Pathol 2012; 180: 1340-55.
4. Driskell RR, Lichtenberger BM, Hoste E, Kretzschmar K, Simons BD, Charalambous M, et al. Distinct fibroblast lineages determine dermal architecture in skin development and repair. Nature 2013; 504: 277-81.
5. Piera-Velazquez S, Li Z, Jimenez SA,. Role of endothelial-mesenchymal transition (EndoMT) in the pathogenesis of fibrotic disorders. Am J Pathol 2011; 179: 1074-80.
6. Fleischmajer R, Damiano V, Nedwich A,. Scleroderma and the subcutaneous tissue. Science 1971; 171: 1019-21.
7. Wu M, Melichian DS, Chang E, Warner-Blankenship M, Ghosh AK, Varga J,. Rosiglitazone abrogates bleomycin-induced scleroderma and blocks profibrotic responses through peroxisome proliferator-activated receptor-γ. Am J Pathol 2009; 174: 519-33.
8. Servettaz A, Goulvestre C, Kavian N, Nicco C, Guilpain P, Chereau C, et al. Selective oxidation of DNA topoisomerase 1 induces systemic sclerosis in the mouse. J Immunol 2009; 182: 5855-64.
9. Stawski L, Han R, Bujor AM, Trojanowska M,. Angiotensin II induces skin fibrosis: a novel mouse model of dermal fibrosis. Arthritis Res Ther 2012; 14: R194.
10. Sonnylal S, Denton CP, Zheng B, Keene DR, He R, Adams HP, et al. Postnatal induction of transforming growth factor β signaling in fibroblasts of mice recapitulates clinical, histologic, and biochemical features of scleroderma. Arthritis Rheum 2007; 56: 334-44.
11. Zhang Y, McCormick LL, Desai SR, Wu C, Gilliam AC,. Murine sclerodermatous graft-versus-host disease, a model for human scleroderma: cutaneous cytokines, chemokines, and immune cell activation. J Immunol 2002; 168: 3088-98.
12. Maurer B, Distler JH, Distler O,. The Fra-2 transgenic mouse model of systemic sclerosis. Vascul Pharmacol 2013; 58: 194-201.
13. Gerber EE, Gallo EM, Fontana SC, Davis EC, Wigley FM, Huso DL, et al. Integrin-modulating therapy prevents fibrosis and autoimmunity in mouse models of scleroderma. Nature 2013; 503: 126-30.
14. Manne J, Markova M, Siracusa LD, Jimenez SA,. Collagen content in skin and internal organs of the tight skin mouse: an animal model of scleroderma. Biochem Res Int 2013; 2013: 436053.
15. Christner PJ, Peters J, Hawkins D, Siracusa LD, Jimenez SA,. The tight skin 2 mouse: an animal model of scleroderma displaying cutaneous fibrosis and mononuclear cell infiltration. Arthritis Rheum 1995; 38: 1791-8.
16. Wei J, Melichian D, Komura K, Hinchcliff M, Lam AP, Lafyatis R, et al. Canonical Wnt signaling induces skin fibrosis and subcutaneous lipoatrophy: a novel mouse model for scleroderma? Arthritis Rheum 2011; 63: 1707-17.
17. Sun K, Tordjman J, Clement K, Scherer PE,. Fibrosis and adipose tissue dysfunction. Cell Metab 2013; 18: 470-7.
18. He W, Barak Y, Hevener A, Olson P, Liao D, Le J, et al. Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle. Proc Natl Acad Sci U S A 2003; 100: 15712-7.
19. Wang ZV, Deng Y, Wang QA, Sun K, Scherer PE,. Identification and characterization of a promoter cassette conferring adipocyte-specific gene expression. Endocrinology 2010; 151: 2933-9.
20. Bing C, Russell S, Becket E, Pope M, Tisdale MJ, Trayhurn P, et al. Adipose atrophy in cancer cachexia: morphologic and molecular analysis of adipose tissue in tumour-bearing mice. Br J Cancer 2006; 95: 1028-37.
21. Milano A, Pendergrass SA, Sargent JL, George LK, McCalmont TH, Connolly MK, et al. Molecular subsets in the gene expression signatures of scleroderma skin. PloS One 2008; 3: e2696.
22. Bhattacharyya S, Wei J, Varga J,. Understanding fibrosis in systemic sclerosis: shifting paradigms, emerging opportunities. Nat Rev Rheumatol 2012; 8: 42-54.
23. Cristancho AG, Lazar MA,. Forming functional fat: a growing understanding of adipocyte differentiation. Nat Rev Mol Cell Biol 2011; 12: 722-34.
24. Rosen ED, Spiegelman BM,. What we talk about when we talk about fat. Cell 2014; 156: 20-44.
25. Driskell RR, Jahoda CA, Chuong CM, Watt FM, Horsley V,. Defining dermal adipose tissue. Exp Dermatol 2014; 23: 629-31.
26. Berry DC, Stenesen D, Zeve D, Graff JM,. The developmental origins of adipose tissue. Development 2013; 140: 3939-49.
27. Rivera-Gonzalez G, Shook B, Horsley V,. Adipocytes in skin health and disease. Cold Spring Harb Perspect Med 2014; 4: a015271.
28. Schmidt BA, Horsley V,. Intradermal adipocytes mediate fibroblast recruitment during skin wound healing. Development 2013; 140: 1517-27.
29. Bereziat V, Cervera P, Le Dour C, Verpont MC, Dumont S, Vantyghem MC, et al, and the Lipodystrophy Study Group. LMNA mutations induce a non-inflammatory fibrosis and a brown fat-like dystrophy of enlarged cervical adipose tissue. Am J Pathol 2011; 179: 2443-53.
30. Bing C, Trayhurn P,. New insights into adipose tissue atrophy in cancer cachexia. Proc Nutr Soc 2009; 68: 385-92.
31. Garg A,. Acquired and inherited lipodystrophies. N Engl J Med 2004; 350: 1220-34.
32. Karnik P, Tekeste Z, McCormick TS, Gilliam AC, Price VH, Cooper KD, et al. Hair follicle stem cell-specific PPARγ deletion causes scarring alopecia. J Invest Dermatol 2009; 129: 1243-57.
33. Kim S, Huang LW, Snow KJ, Ablamunits V, Hasham MG, Young TH, et al. A mouse model of conditional lipodystrophy. Proc Natl Acad Sci U S A 2007; 104: 16627-32.
34. Clouthier DE, Comerford SA, Hammer RE,. Hepatic fibrosis, glomerulosclerosis, and a lipodystrophy-like syndrome in PEPCK-TGF-β1 transgenic mice. J Clin Invest 1997; 100: 2697-713.
35. Zeve D, Seo J, Suh JM, Stenesen D, Tang W, Berglund ED, et al. Wnt signaling activation in adipose progenitors promotes insulin-independent muscle glucose uptake. Cell Metab 2012; 15: 492-504.
36. Kang S, Kong X, Rosen ED,. Adipocyte-specific transgenic and knockout models. Methods Enzymol 2014; 537: 1-16.
37. Lee KY, Russell SJ, Ussar S, Boucher J, Vernochet C, Mori MA, et al. Lessons on conditional gene targeting in mouse adipose tissue. Diabetes 2013; 62: 864-74.
38. Wang QA, Scherer PE, Gupta RK,. Improved methodologies for the study of adipose biology: insights gained and opportunities ahead. J Lipid Res 2014; 55: 605-24.
39. Jeffery E, Berry R, Church CD, Yu S, Shook BA, Horsley V, et al. Characterization of Cre recombinase models for the study of adipose tissue. Adipocyte 2014; 3: 206-11.
40. Liu S, Herault Y, Pavlovic G, Leask A,. Skin progenitor cells contribute to bleomycin-induced skin fibrosis. Arthritis Rheumatol 2014; 66: 707-13.
41. + perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nat Med 2012; 18: 1262-70.
42. Bochet L, Lehuede C, Dauvillier S, Wang YY, Dirat B, Laurent V, et al. Adipocyte-derived fibroblasts promote tumor progression and contribute to the desmoplastic reaction in breast cancer. Cancer Res 2013; 73: 5657-68.
43. Desai VD, Hsia HC, Schwarzbauer JE,. Reversible modulation of myofibroblast differentiation in adipose-derived mesenchymal stem cells. PloS One 2014; 9: e86865.
44. Duffield JS, Lupher M, Thannickal VJ, Wynn TA,. Host responses in tissue repair and fibrosis. Ann Rev Pathol 2013; 8: 241-76.
45. Rock JR, Barkauskas CE, Cronce MJ, Xue Y, Harris JR, Liang J, et al. Multiple stromal populations contribute to pulmonary fibrosis without evidence for epithelial to mesenchymal transition. Proc Natl Acad Sci U S A 2011; 108: E1475-83.
46. Goritz C, Dias DO, Tomilin N, Barbacid M, Shupliakov O, Frisen J,. A pericyte origin of spinal cord scar tissue. Science 2011; 333: 238-42.
47. LeBleu VS, Taduri G, O'Connell J, Teng Y, Cooke VG, Woda C, et al. Origin and function of myofibroblasts in kidney fibrosis. Nat Med 2013; 19: 1047-53.